Search

AB Science SA

Uždarymo kaina

0.45 -19.06

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

0.45

Max

0.538

Pagrindiniai rodikliai

By Trading Economics

Pajamos

3.6M

Pardavimai

659K

Pelno marža

549.317

Darbuotojai

26

EBITDA

1.3M

Dividendai

By Acuity

Kitas uždarbis

2026-10-09

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

67M

Ankstesnė atidarymo kaina

19.51

Ankstesnė uždarymo kaina

0.45

AB Science SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-10-03 23:31; UTC

Brazil's September Inflation Rate Release on October 9 Expected to Show Significant Change Amid Global Price Pressures.

2026-10-03 23:31; UTC

Brazil's September inflation rate report on October 9, 2026, could influence market sentiment and investment strategies amid rising price concerns ahead of presidential elections.

2026-10-03 23:11; UTC

Mexico's Inflation Rate MoM Release on October 8, 2026 Expected to Impact Market Sentiment Amid Global Economic Pressures.

2026-10-03 23:11; UTC

Mexico's Inflation Rate Expected to Rise in September 2026 Amid Global Price Pressures, Analysts Warn of Economic Implications

2026-10-03 22:51; UTC

Macro News

The Nasdaq 100 Index (US) declined in after-market trading, influenced by concerns over $3.8 trillion in off-balance sheet debt among major hyperscalers.

2026-10-03 22:51; UTC

Macro News

The Dow Jones Index traded lower in after-market hours amid concerns over $3.8 trillion in off-balance sheet liabilities in the hyperscaler industry.

2026-10-03 22:51; UTC

Japan's Household Spending Data Release on October 8 Expected to Reflect Consumer Trends Amid Rising Inflation and Market Caution.

2026-10-03 22:51; UTC

Japan's Household Spending YoY Expected to Decline Further Amid Rising Inflation and Economic Uncertainty

2026-10-03 22:51; UTC

Japan's Current Account Release on October 7 Expected to Reflect Economic Health Amid Mixed Consumer Price Sentiment and Global Demand Concerns.

2026-10-03 22:50; UTC

Macro News

The FTSE 100 Index traded modestly higher during after-market hours, amid rising U.S. Treasury yields and volatile Brent crude oil prices.

2026-10-03 22:11; UTC

UK Housing Market Outlook Remains Cautiously Pessimistic Ahead of RICS House Price Balance Report, Forecasting -0.3% Decline

2026-10-03 22:11; UTC

U.S. 30-Year Mortgage Rates Expected to Rise Amid Inflation Concerns and Weak Job Growth, Impacting Housing Affordability

2026-10-03 21:51; UTC

Australia's Westpac Consumer Confidence Index set for October 5 release amid positive investor sentiment and market recovery, despite global economic uncertainties.

2026-10-03 21:51; UTC

Australia's Consumer Confidence Report on October 5, 2026, amid cautious optimism following a sharp September decline and ongoing inflationary pressures.

2026-10-03 21:50; UTC

Palladium is trading higher since Friday's close, despite remaining significantly below its 20-day moving average amid ongoing volatility in energy prices.

2026-10-03 21:31; UTC

Spain's Consumer Confidence Index Set for Release Amid Mixed Market Sentiment and Geopolitical Tensions on October 9, 2026.

2026-10-03 20:41; UTC

Australia's Ai Group Industry Index set for release on October 6, with expectations of recovery from August's -3.5 amid cautious optimism in the stock market and potential positive impacts on related sectors.

2026-10-03 20:21; UTC

Turkey's Trade Balance Data Release on October 5, 2026: Market Anticipates Widening Deficit Amid Global Economic Pressures.

2026-10-03 20:21; UTC

API Crude Oil Stock Change Report Due October 6, Amid Market Volatility and Geopolitical Tensions Impacting Energy Prices.

2026-10-03 19:31; UTC

Euro Area Retail Sales Expected to Rise 0.4% Amid Mixed Consumer Trends and Rising Inflation

2026-10-03 19:31; UTC

Italy's Industrial Production MoM data for August 2026 set to release on October 9, with market expectations at a flat growth of 0.0% amid mixed economic signals and recent retail sales increase.

2026-10-03 18:41; UTC

The Nikkei 225 Index is advancing in after-market hours, continuing its rise from Friday's close amid concerns over market concentration and volatility.

2026-10-03 18:40; UTC

GBP/CAD is roughly flat as the market remains closed for the weekend, reflecting stability near the upper end of its one-month trading range.

2026-10-03 18:40; UTC

Macro News

Oil prices are modestly higher since Friday's close, driven by U.S. sanctions impacting Iran's oil revenue streams during the weekend market closure.

2026-10-03 18:31; UTC

Switzerland's Consumer Confidence Index for September 2026 forecasted at -31.0, reflecting ongoing negative sentiment amid mixed global economic signals and upcoming central bank decisions.

2026-10-03 18:31; UTC

Turkey's Industrial Production YoY data release on October 9, 2026, signals ongoing economic contraction concerns amid declining output trends.

2026-10-03 18:01; UTC

Italy's S&P Global Services PMI set for October 5, with expectations of moderate growth at 53.0 amid cautious market sentiment influenced by global economic concerns.

2026-10-03 17:41; UTC

France's Balance of Trade report on October 7, 2026, anticipates a €6.5 billion deficit amid rising inflation and import dependency concerns.

2026-10-03 17:41; UTC

Switzerland's Unemployment Rate Release on October 6 Expected to Reflect Labor Market Stability Amid Global Economic Volatility.

2026-10-03 17:31; UTC

Spain's S&P Global Services PMI for September 2026 set to release on October 5, with analysts predicting a slight decline from August’s strong reading amid cautious market sentiment.

Akcijų palyginimas

Kainos pokytis

AB Science SA Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

0

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę AB Science SA

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.